Since up to 80 percent of pregnant women and 30 percent of neonates may be colonized with genital mycoplasmas, it is difficult to determine whether true infection occurs. The antibody responses to eight serotypes of U. urealyticum were assessed in mothers and infants in 21 cases of neonatal respiratory disease (RD) and 24 normal cases. Among the normal population of mothers and infants, a titer of 2 1:32 occurred in 0.25 percent (1/394). In mother-infant paired titers, a fourfold difference occurred in 2.6 percent (5/192). Among 54 RD neonates, 55.6 percent had a titer of a 1:32 compared to only 4.2 percent of normal neonates (p < .001). Fourfold elevations in antibody titers of > 1:32 were observed in the neonate in 52.4 percent of RD cases compared to 0 perecnt of 24 normal pairs (p < .001) and in 28.6 percent of mothers of RD neonates compared to 0 percent in normal cases (p = .013). We observed that 43.3 percent of RD neonates with titers a 1:32 died compared to 16.6 percent of RD neonates exhibiting no elevation of antibody response over the maternal level. Among the six who died, 66.7 percent of neonates and 16.7 percent of their mothers had elevated titers, compared to 33.3 percent of 15 surviving infants and 40.0 percent of their mothers. These elevated antibody responses strongly support the concept that U. urealyticum causes infection in the perinatal period in association with neonatal respiratory disease. Since the elevation in titers was detected close to delivery in many cases, the infection may occur in utero.
INTRODUCTION
Asymptomatic mycoplasma colonization occurs in 6-75 percent of adults and up to 80 percent of pregnant women. Newborns are colonized at birth in 15-33 percent of cases [1] . The presence of Ureaplasma urealyticum and/or Mycoplasma hominis in placentas is associated with chorioamnionitis, low birth weight, and a significantly higher rate of spontaneous abortion, prematurity, perinatal morbidity, and mortality [1] [2] [3] [4] . Mycoplasmas have been isolated from amniotic fluid [1, 5] and are associated with spontaneous abortion and congenital pneumonia [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] .
Mycoplasmas from the genital tract have been associated with fetal pneumonia in spontaneous abortion and congenital pneumonia in neonates based on the isolation of the organism and histological evidence of inflammation in the lung [6] [7] [8] [9] [10] . In a recent case of congenital pneumonia based on isolation and immunospecific staining of the lung tissue, intrauterine infection was confirmed by the presence of an elevated antibody titer at birth and the presence of IgM specific antibody at 74 hours of age, suggesting infection began in utero [11] . Spontaneous abortion and "weak calf syndrome" (with respiratory distress) were also observed in bovines infected in pregnancy with U. diversum isolated from an aborted calf [12] .
The possibility of intrauterine infection has been difficult to assess because isolation of the organism does not distinguish between intra-partum colonization and true infection. In this paper, serological data on infants born with respiratory disease support the concept that U. urealyticum causes lung disease in neonates of varying gestational ages.
MATERIALS AND METHODS Patients
Antibody levels were determined on paired mother-infant sera from (a) 24 normal healthy deliveries taken at birth, and (b) 21 pairs plus 33 neonates who were born with respiratory disease (RD) of unknown etiology which was fatal or developed a protracted course. These neonates were born between 25-40 weeks of gestation with sera drawn one to 20 days after delivery.
Serology
The paired sera were assayed simultaneously by a modified metabolic inhibition test [13, 14] for eight serotypes of U. urealyticum. The strains used were as follows: Serotype 1 (strain 7), 2 (strain 23), 3 (strain 27), 4 (strain 58), 5 (strain 354), 6 (strain Pi), 7 (strain Co), and 8 (strain T960-CX8). The strains were obtained from Dr. R. Purcell at the National Institutes of Health, Bethesda, MD. Trypticase soy broth [3] supplemented with 20 percent horse serum (K.C. Biologicals), 10 percent of fresh yeast extract (25 percent w/v), 10 percent guinea pig serum (Gibco), 0.1 percent urea, and 0.004 percent bromothymol blue was used. Each assay was done with 102 and 103 ccu/ml final concentration of ureaplasma as recommended by Lin [14] . The initial dilution of serum assayed was 1:8 since the organism and media were added at the same time prior to incubation. The titer was read when the control cups containing ureaplasma without patient sera had changed 0.5 to 0.75 pH units. Plates were read every 30 minutes once the color changes started. The endpoint was recorded as the highest dilution of serum which inhibited growth and held constant for two consecutive readings (at least 30 minutes). Occasionally, when control cups did not turn positive by day end, the plates were put at 30°C overnight. In most cases the titer was the same. The plate was re-incubated at 36°C and read throughout the day. This was essential since different serotypes grew at different rates. A pattern of inhibition of one dilution less for 103 ccu/ml from the reading at 102 ccu/ml was used as a guide to control for spotting (lack of growth) in some cups of the microtiter plates.
Statistical Methods
Comparisons of the frequency of elevated titers used Chi2 or Fisher's exact test when expected frequencies were small. Means of mothers and neonates in the RD group were compared to normal mothers and neonates using a t-test and the logarithm of the antibody titers. Titers of < 1:8 were taken as 1:4 to calculate means. The means of the log titers have been converted back to the observed scale of dilutions for presentation in Table 2 and Fig. 1 
RESULTS

Comparison of Antibody Titers to U. urealyticum in Normal Deliveries
Antibody titers to eight serotypes were determined on 24 randomly selected mother-infant pairs with normal gestation, delivery, and healthy neonates. In the 192 paired MI tests, the mother's titer was equal to that of the neonate in 71.9 percent of the assays. A twofold difference either way was observed in 25.5 percent. A fourfold difference between the mother's and infant's titer to a given serotype was observed in only 2.6 percent of cases. We therefore considered a titer fourfold higher to be significantly elevated Mortality Rate with U. urealyticum Infection To correlate the effect of U. urealyticum as a cause of severe disease, the mortality rate was assessed according to the degree of elevation in titers (Table 1) . Among neonates with a titer of 2 1:32, 43.3 percent (13/30) died. Among 10 neonates with a 4 x elevation above the maternal level, 40 percent died compared to 16.6 percent of 12 whose titers were the same or less than their mother's. In the first group of six who died, five had these elevated titers to serotype 8 whereas in the group of five which survived only one had an elevated titer to serotype 8. In the six cases of death with paired sera, 66.7 percent of neonates and only 16.7 percent of the mothers had 4 x elevated titers. In comparison among the 15 survivors, 33.3 percent of neonates and 40 percent of their mothers had elevated titers to at least one ureaplasma serotype. These groups are not appropriate for statistical analysis because of group size and the fact that an IgM specific titer of < 1:16 may be indicative of infection in very premature neonates. In all cases where U. urealyticum infection was suspected, the neonates were treated with erythromycin and/or chloramphenicol.
Comparison of the Mean Antibody Titers
To assess whether there was a difference in the antibody titers observed in the neonates born with respiratory disease compared to normal neonates, the mean titers were calculated for each serotype (Table 2 ). In the RD case, the neonates had significantly elevated mean titers to serotypes 4, 7, and 8 when compared to the mean titers of the normal neonates and slight but not significant elevations to serotypes 3 and 6. Among the 21 pairs, ten neonates and seven mothers exhibited a 4 x elevation with both observations occurring in three cases.
When the RD cases were assessed according to whether the infant survived or died (Table 2 ), certain differences in the mean titers were observed. The mean titer to serotype 3 was slightly elevated in all groups. With serotypes 4 and 8, the mean titers were significantly higher among neonates who died than among the survivors. For serotype 5, a significant elevation occurred only among the survivors. The elevation In the cases of the very premature neonates, 22-30 weeks' gestation, the elevation in titers tended to be low, e.g., 1:8 to 16 or 1:8 to 1:32 for mother vs. neonate, but with some neonates as high as 1:256. In the infants born after 30 weeks, the titers ranged from 1:8 to 1:32 up to 1:8 to 1:128. Since the mothers can have high titers due to IgG which crosses the placenta, a high neonatal titer may not be indicative of neonatal infection. DISCUSSION U. urealyticum has been considered an infectious agent in pregnancy, leading to a poor outcome [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] , but a causal role is difficult to assess. Colonization may occur before or after the death of the fetus, after an extended period of ruptured membranes, or the organism may be aspirated during delivery. Second, the inflammatory response in lungs and placenta may be due to other microorganisms not detected. However, elevation in IgM antibodies to the same ureaplasma serotype isolated from the lung [11] is indicative of true infection. In the bovine model, inoculation of pregnant cows with U. diversum at five months of gestation resulted in abortion or severe respiratory distress. The organism was isolated and an inflammatory response was observed in the lungs, similar to that observed in humans [12] . These observations support the hypothesis that the living fetus may be infected with ureaplasmas in utero.
In this study elevated antibody responses to specific U. urealyticum serotypes were found in infants at delivery. A number of situations are therefore possible. The mother had the infection prior to conception with circulating IgG antibody which crossed to the fetus, resulting in equal titers. In the second group, infection is established in the mother prior to conception or during pregnancy such that she has or develops an antibody response of the IgM class. Because these antibodies do not cross to the fetus, the mother has a higher titer than the neonate. In the third case, infection occurs on the fetal side on the immunological barrier. The fetus develops its own 1gM specific antibody response which does not cross to the maternal circulation. The neonate, therefore, has an elevated titer over the maternal level. In a few cases this elevated titer was proven to be IgM-specific [11; unpublished results] . Finally, the mother could have IgG plus IgM. The fetus acquires maternal IgG but synthesizes its own IgM, which results in high titers in both mother and fetus. The situation is complex because of the large number of serotypes which could elicit these antibody responses. In one case, the mother had elevated titers to serotypes 6 and 7, while the neonate had elevated titers to serotypes 2 and 4.
The mean titers were assessed to determine which serotypes elicited a significant antibody response. A small elevation in the mean titer was observed to serotype 3 in both the normal and RD groups and was also found in the spontaneous abortion group. Since 80 percent of the local population, whether fertile or infertile, carry serotype 3 compared to 20 percent or less for the other serotypes [16] , one would expect an antibody response comparable in all groups. In the RD cases, the neonates had elevated titers to serotypes 4, 7, and 8, but the mothers did not to a significant degree. In mycoplasma-positive women with a history of pregnancy loss (PL), the maternal titers were elevated to serotypes 4 and 8, and to 6 and 8 in the neonates [15] . Since the significantly elevated antibody responses do not occur to serotype 3 but to serotypes 4, 6, 7, and 8, the data suggest that serotype 3 may exist as a commensal while serotypes 4, 6, and particularly 8 may be more pathogenic.
In abortion, U. urealyticum appears to play a causal role. An inflammatory response in the lungs or lesion in the tracheal epithelium may or may not be observed [8] . In our studies, neonates of 22-28 wveeks' gestation exhibited fourfold higher titers than their mothers. This fact supports the concept that the fetus is infected in utero, eliciting its own immune response. In our studies of abortion associated with genital mycoplasmas there is a marked trend in which 40 percent of pregnancies are lost later in the second trimester. Why some infected fetuses are live rather than aborted or stillborn is not known. However, it is possible that those infants in whom antibodies develop or who acquire antibodies from their mothers, cope with the infection better, resulting in a live birth. Finally, among the healthy neonates of erythromycin-treated PL mothers [17] , the antibody response to serotype 8 was most significant as it was for RD neonates who died. This fact suggests that erythromycin therapy during gestation prevented severe disease in the fetus, resulting in healthy neonates.
In conclusion, the development of an immune response to the presence of U. urealyticum supports the concept that this organism is capable of causing fetal/neonatal infection. Women may be colonized with U. urealyticum but exhibit no clinical signs of disease. However, in certain women and during pregnancy, the organism may cause infection in the mother and/or the fetus which results in abortion, stillbirth, prematurity, and severe congenital pneumonia or chronic respiratory disease in the neonate.
